Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bridging Study to Evaluate Safety of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 5 Years Old

NCT02729168 is registered in ClinicalTrials.gov with Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products as lead sponsor.

NCT NCT02729168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02729168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Bridging Study to Evaluate Safety of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 5 Years Old
Lead sponsor
Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2015
Completion date
December 31, 2015
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rabies